EFFICACY AND SAFETY OF DUPILUMAB MONOTHERAPY IN CHINESE ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RATIONALE AND DESIGN OF A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE III TRIAL

被引：0
|
作者：
Zhao, Yan [1 ]
Lu, Qianjin [2 ]
Gao, Xinghua [3 ]
Liu, Lingling [4 ]
Li, Wei [5 ]
Song, Zhiqiang [6 ]
Yao, Zhirong [7 ]
Yao, Xu [8 ]
Hao, Nan [9 ]
Zhang, Jianzhong [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Dermatol, Hunan Key Lab Med Epigenom, Changsha, Hunan, Peoples R China
[3] China Med Univ, Hosp 1, NHC Key Lab Immunodermatol, Minist Educ,Key Lab Immunodermatol,Dept Dermatol, Shenyang, Peoples R China
[4] Peking Univ First Hosp, Dept Dermatol, Beijing, Peoples R China
[5] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China
[6] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China
[7] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Dermatol, Shanghai, Peoples R China
[8] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China
[9] Sanofi, Med Dept, Shanghai, Peoples R China
来源：
ACTA DERMATO-VENEREOLOGICA | 2021年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
PT4
引用
收藏
页码：52 / 53
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [22] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    ONCOTARGET, 2017, 8 (65) : 108480 - 108491
  • [23] Lebrikizumab in combination with topical corticosteroids improves quality of life in patients with moderate-to-severe atopic dermatitis: results from a phase III randomized, double-blinded, placebo-controlled trial (ADhere)
    Forman, Seth
    Gutermuth, Jan
    de Bruin-Weller, Marjolein
    Moore, Angela
    Guenthner, Scott
    Wolf, Eric
    Pierce, Evangeline
    Witte, Michael M.
    Zhong, Jinglin
    Wollenberg, Andreas
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E109 - E109
  • [24] EFFICACY AND SAFETY OF IXEKIZUMAB IN A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 3B CLINICAL TRIAL IN PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Yang, F. E.
    Bleakman, Potts A.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : S6 - S7
  • [25] Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis
    Ryan, Caitriona
    Menter, Alan
    Guenther, Lyn
    Blauvelt, Andrew
    Bissonnette, Robert
    Yang, Fan Emily
    Bleakman, Alison Potts
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 13 - 14
  • [26] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Yang, F. E.
    Bleakman, A. Potts
    Burkhardt, N.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 42 - 42
  • [27] Efficacy and safety of plecanatide in Chinese patients with functional constipation: A phase III randomized, double-blinded, placebo-controlled, multicenter trial
    Bai, Tao
    Xu, Zhiyue
    Jiang, Yueping
    Zhao, Hong
    Yan, Peng
    Dai, Ning
    Chen, Xi
    Huang, Kunming
    Cui, Jun
    Xu, Min
    Jia, Shujuan
    Zhang, Juan
    Liu, Side
    Li, Xiaoqing
    Ai, Yaowei
    Zhang, Mingxin
    Wu, Yongdong
    Zhou, Weizhen
    Zhao, Rong
    Wu, Jianjun
    Wang, Bangmao
    Xu, Baohong
    Ding, Xiangwu
    Fang, Xiangming
    Yang, Shaoqi
    Ma, Yingcai
    Zhou, Zhongyin
    Lin, Lin
    Chen, Huixin
    Zhang, Heng
    Zhu, Yin
    Jiang, Bo
    Zhang, Xiaolan
    Wang, Xiaoyan
    Zou, Duowu
    Ye, Bin
    Zhang, Ling
    Shi, Ruihua
    Zhen, Yanbo
    Wang, Junping
    Liu, Youli
    Liao, Aijun
    Hou, Xiaohua
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36
  • [28] Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
    Guttman-Yassky, Emma
    Silverberg, Jonathan I.
    Nemoto, Osamu
    Forman, Seth B.
    Wilke, August
    Prescilla, Randy
    de la Pena, Amparo
    Nunes, Fabio P.
    Janes, Jonathan
    Gamalo, Margaret
    Donley, David
    Paik, Jim
    DeLozier, Amy M.
    Nickoloff, Brian J.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 913 - +
  • [29] Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Simpson, Eric L.
    Tyring, Stephen K.
    Purcell, Lisa A.
    Shumel, Brad
    Petro, Christopher D.
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Evans, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 158 - +
  • [30] EFFICACY AND SAFETY OF TRALOKINUMAB IN A KOREAN SUBPOPULATION OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A SUBANALYSIS OF ECZTRA 2, A PHASE 3, MONOTHERAPY, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL
    Kim, Kyu Han
    Son, Sang Wook
    Lee, Yang Won
    Simpson, Eric L.
    Kuznetsova, Alexandra
    Cho, Sang Hyun
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 63 - 63
12345